Wealth Enhancement Trust Services’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-81
Closed -$1.18K – 1408
2026
Q2
$1.18K Hold
81
– – ﹤0.01% 1089
2026
Q1
$1.54K Buy
+81
New +$1.31K ﹤0.01% 704

Other funds holding SMMT

Wealth Enhancement Trust Services's SMMT Position: Q3 2026 in Review

Wealth Enhancement Trust Services sold out of Summit Therapeutics (SMMT) in Q3 2026, closing a stake of 81 shares — an estimated $1.18K sold.

Wealth Enhancement Trust Services first reported a position in SMMT in Q1 2026 and held it in 2 quarters. The position peaked at $1.54K in Q1 2026. 295 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.

  • Wealth Enhancement Trust Services reported no remaining Summit Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Wealth Enhancement Trust Services sold 81 Summit Therapeutics shares in Q3 2026, an estimated $1.18K.
  • Wealth Enhancement Trust Services first reported a position in Summit Therapeutics in Q1 2026 and held it in 2 quarters.
  • Wealth Enhancement Trust Services's Summit Therapeutics position peaked at $1.54K in Q1 2026.
  • 295 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q3 2026, filed 7 Oct 2026.